Kornitzer Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Kornitzer Capital Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-103,000	Closed	-$740K	–	491
2016 Q4	$740K	Hold	103,000	–	–	0.01%	394
2016 Q3	$964K	Sell	103,000 -69,300	-40%	-$576K	0.02%	366
2016 Q2	$1.09M	Sell	172,300 -9,100	-5%	-$58.5K	0.02%	358
2016 Q1	$1M	Sell	181,400 -115,000	-39%	-$432K	0.02%	355
2015 Q4	$1.65M	Hold	296,400	–	–	0.03%	325
2015 Q3	$2.51M	Buy	296,400 +140,000	+90%	+$2.37M	0.04%	297
2015 Q2	$2.37M	Hold	156,400	–	–	0.03%	321
2015 Q1	$2.5M	Sell	156,400 -51,000	-25%	-$907K	0.03%	310
2014 Q4	$3.7M	Buy	207,400 +166,000	+401%	+$2.07M	0.04%	276
2014 Q3	$416K	Buy	+41,400	New	+$502K	﹤0.01%	365

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Kornitzer Capital Management's PETX Position: Q1 2017 in Review

Kornitzer Capital Management sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2017, closing a stake of 103,000 shares — an estimated $740K sold.

Kornitzer Capital Management first reported a position in PETX in Q3 2014 and held it in 10 quarters. The position peaked at $3.7M in Q4 2014. 98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

Kornitzer Capital Management reported no remaining Aratana Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
Kornitzer Capital Management sold 103,000 Aratana Therapeutics, Inc. shares in Q1 2017, an estimated $740K.
Kornitzer Capital Management first reported a position in Aratana Therapeutics, Inc. in Q3 2014 and held it in 10 quarters.
Kornitzer Capital Management's Aratana Therapeutics, Inc. position peaked at $3.7M in Q4 2014.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2017.

Based on Kornitzer Capital Management's 13F filing for Q1 2017, filed 1 May 2017.